Efficacy and safety of allergen-specific immunotherapy for allergic asthma: a meta-analysis comparing sublingual and subcutaneous routes across allergen types and age groups - PubMed
2 hours ago
- #allergen-specific immunotherapy
- #allergic asthma
- #meta-analysis
- Allergen-specific immunotherapy (AIT) is effective in improving asthma symptoms and reducing medication use.
- Subcutaneous immunotherapy (SCIT) shows greater efficacy than sublingual immunotherapy (SLIT).
- AIT is effective against both house dust mite and grass pollen allergies.
- Treatment duration and age do not significantly impact the outcomes of AIT.
- AIT improves medication scores and positively impacts FEV1.
- AIT does not increase local side effects but significantly increases systemic reactions.